3
Announcements
Trials
Browse
Landscape
Status
Completed
7
Unknown
4
Recruiting
2
Terminated
1
Suspended
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
190
Thoracic
14
Gynecologic
9
Breast
7
Sarcoma
5
Head & Neck
5
Genitourinary
5
CNS
4
Dermatologic
3
Other neoplasm
2
Other hematologic neoplasm
2
Plasma cell
1
Other solid neoplasm
1
Other
1
Myeloid
1
Lymphoid
1
Conditions
Multiple Myeloma
477
Neoplasms, Plasma Cell
102
Lymphoma
86
Lymphoma, Non-Hodgkin
75
Leukemia, Lymphocytic, Chronic, B-Cell
72
Myelodysplastic Syndromes
71
Recurrence
68
Leukemia, Myeloid, Acute
68
Leukemia
68
Precursor Cell Lymphoblastic Leukemia-Lymphoma
67
Hodgkin Disease
66
Lymphoma, Mantle-Cell
53
Lymphoma, Large B-Cell, Diffuse
53
Lymphoma, Follicular
45
Myeloproliferative Disorders
43
Neoplasms
41
Lymphoma, B-Cell, Marginal Zone
41
Burkitt Lymphoma
41
Primary Myelofibrosis
38
Lymphoma, Large-Cell, Immunoblastic
36
Lymphoma, T-Cell, Cutaneous
31
Leukemia, Myelomonocytic, Chronic
31
Sezary Syndrome
29
Mycosis Fungoides
29
Leukemia, Myeloid, Chronic-Phase
29
Leukemia, Myeloid, Accelerated Phase
29
Congenital Abnormalities
29
Leukemia, Hairy Cell
27
Blast Crisis
27
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Rectal Neoplasms
×
Plasma cell
×
Clear all
NCT02900248
2019-04-02
N1
CureOne
Terminated
23 enrolled